Project Grant K43TW012840

Award Date 9/1/24
Completion Date 8/31/29
Dollars Obligated $63K
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
South Africa
Similar Awards
This Project Grant award of $197,035 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year study to design and evaluate a community-based intervention to engage men who use alcohol and substances in HIV prevention services in rural South Africa. The primary objectives are to: 1) explore perceptions and preferences for HIV prevention services among men who frequent local bars (shebeens), 2) develop an intervention...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $180,946 to develop and evaluate a stepped implementation approach for delivering problem-solving therapy to people living with HIV in South Africa. The key products and services to be delivered include: Determining stakeholder preferences for implementing problem-solving therapy through qualitative research with people living with HIV and HIV/mental...
This $233,335 National Institute of Mental Health project grant supports the adaptation and optimization of the Friendship Bench mental health intervention for adolescent girls and young women in South African HIV pre-exposure prophylaxis (PrEP) delivery settings. The University of Washington will receive funding to support Dr. Jennifer Velloza's development as an independent researcher focused on improving mental health intervention delivery integrated with HIV prevention services for young...
The National Institute of Mental Health (NIMH) awarded a $1,300,224 Project Grant under the Mental Health Research Grants (CFDA 93.242) program to The Johns Hopkins University to conduct a study titled "HOMELINK2: Reducing Posthospitalization Mortality Among People Living with HIV Through Structured Home Care and Nutritional Supplementation." The project aims to evaluate the effectiveness of a home-based intervention involving structured post-hospitalization home visits with...
This $198,531 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to develop and pilot test an integrated intervention that addresses mental health and HIV medication adherence among men who have sex with men (MSM) in South Africa. The proposed "WECARE" intervention will be based on principles of problem-solving therapy, minority stress theory, and a status-neutral approach to target both mental...
The National Institute of Mental Health (NIMH) awarded a $780,447 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Brigham & Women's Hospital Inc. to test a differentiated service delivery model called CARES-DSD to improve engagement and viral suppression among people with HIV who have experienced treatment interruptions in South Africa. The 5-year project will recruit 300 participants from an ongoing study and evaluate the effectiveness of the CARES-DSD intervention compared...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $1,927,030 to the University of Miami to implement and evaluate strategies for increasing the reach of evidence-based treatments for depression and adherence among persons with HIV in South Africa. The key products and services to be delivered include: 1) Comparing a core set of implementation strategies (e.g. nurse training, mental health stigma...
This $244,814 Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) will fund a mixed-methods research study to investigate the social and behavioral drivers of HIV risk among South African adolescent girls and young women (SA-AGYW). The primary objectives are to: 1) conduct secondary analyses of baseline data from an existing HIV prevention intervention to examine the roles of mental health...
This is a five-year K23 career development grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) in the amount of $201,006. The goal of the project is to develop and pilot test a "Healthy Welcome" intervention to support migrant men in South Africa in starting and adhering to pre-exposure prophylaxis (PrEP) to prevent HIV. The grant recipient, Brigham & Women's Hospital (a subsidiary of the larger Partners...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $661,237 over 5 years to The Ohio State University to conduct research on optimizing brief coping skills interventions for suicide prevention. The study aims to intensively characterize the contexts in which patients at high risk for suicide are most likely to use and benefit from their safety planning interventions, leveraging technology and...

DEVELOPING A SUICIDE PREVENTION INTERVENTION FOR PEOPLE WITH HIV IN SOUTH AFRICA - PROJECT SUMMARY/ABSTRACT BACKGROUND: SUICIDE IN PEOPLE WITH HIV (PWH) IS AN UNADDRESSED PUBLIC MENTAL HEALTH CONCERN IN SOUTH AFRICA. RESEARCH ON SUICIDAL IDEATION AND BEHAVIOR IS SCANT IN LOW- AND MIDDLE-INCOME COUNTRIES (LMIC), DESPITE EVIDENCE SUGGESTING THAT PWH ARE CONFRONTED WITH SYNERGISTIC PSYCHOSOCIAL AND SITUATIONAL STRESSORS THAT INCREASE THEIR RISKS FOR SUICIDE AND ADVERSELY AFFECT HIV CARE ENGAGEMENT, INCLUDING DELAYED TREATMENT INITIATION, POOR ADHERENCE, AND VIRAL INSTABILITY. YET, THERE HAS BEEN NO RESEARCH INVESTIGATING BEHAVIORAL INTERVENTIONS FOR SUICIDE IN PWH IN SOUTH AFRICA. RESEARCH: THE STUDY'S SPECIFIC AIMS ARE TO 1) EXPLORE PRIMARY HEALTHCARE-LEVEL SUICIDE TREATMENT PRACTICES, GAPS, NEEDS, AND IDEAL INTERVENTION CHARACTERISTICS AMONG STAKEHOLDERS AND PWH; 2A) DEVELOP A BRIEF BEHAVIORAL INTERVENTION ADDRESSING SUICIDE AND HIV CARE ENGAGEMENT (MI-COPE-CARE); 2B) REFINE MI-COPE-CARE IN AN ITERATIVE, SEQUENTIAL PRE-PILOT STUDY; AND 3) EVALUATE THE FEASIBILITY, ACCEPTABILITY, AND PRELIMINARY EFFECTIVENESS OF MI-COPE-CARE IN A PILOT RANDOMIZED CONTROLLED TRIAL. IF FOUND TO BE FEASIBLE AND ACCEPTABLE, MI-COPE-CARE WILL BE THE FIRST SUICIDE INTERVENTION FOR PWH IN SOUTH AFRICA. THIS STUDY SUPPORTS NIH HIV/AIDS RESEARCH PRIORITIES TO REDUCE MENTAL HEALTH COMORBIDITIES OF HIV AND STRENGTHEN THE HIV CARE CONTINUUM. CANDIDATE: I AM A RESEARCH PSYCHOLOGIST WITH EXPERTISE IN CROSS-CULTURAL PSYCHOLOGY AND COMMUNITY- BASED BEHAVIORAL INTERVENTIONS IN RESOURCE-CONSTRAINED SETTINGS. THIS CAREER DEVELOPMENT AWARD WILL AFFORD ME THE NECESSARY SKILLS, TRAINING, MENTORSHIP, AND PROTECTED TIME TO BECOME AN INDEPENDENT, NIH-FUNDED INVESTIGATOR DEVELOPING INTERVENTIONS THAT ADDRESS SUICIDE AND HIV CARE ENGAGEMENT AMONG PWH IN SOUTH AFRICA AND OTHER LOW- AND MIDDLE-INCOME COUNTRIES (LMICS). MENTORSHIP: DR. JOHN JOSKA WILL SERVE AS MY PRIMARY SA- BASED MENTOR GIVEN HIS EXPERIENCE IN MENTAL HEALTH AND HIV AND IMPLEMENTING BEHAVIORAL INTERVENTIONS IN SOUTH AFRICA. DR. KATHLEEN SIKKEMA WILL BE MY PRIMARY US-BASED MENTOR DUE TO HER EXPERTISE IN TRAUMA AND HIV, AND EXPERIENCE IN TRIAL DESIGN AND INTERVENTION DEVELOPMENT IN RESOURCE-LIMITED SETTINGS. MY CO-MENTORS WILL BE DR. JASON BANTJES GIVEN HIS EXPERTISE IN SUICIDE RESEARCH IN SOUTH AFRICA, AND DR. EWA CZYZ BECAUSE OF HER EXPERIENCE IN DEVELOPING BRIEF INTERVENTIONS FOR SUICIDE RISK. I HAVE ASSEMBLED A STRONG TEAM OF STUDY CONSULTANTS: DR. DULEEKA KNIPE (SOCIAL DETERMINANTS OF SUICIDE); DR. JESSICA MAGIDSON (MOTIVATIONAL INTERVIEW-INFORMED INTERVENTIONS); DR. MARTINA PAVLICOVA (BIOSTATISTICS); AND DR. DUOVANDRE JANSEN (SUICIDE RISK MANAGEMENT). TRAINING: I PROPOSE TO OBTAIN TRAINING IN INTERVENTION DEVELOPMENT USING THE NIH STAGE MODEL, GAIN EXPERTISE IN TREATMENT FRAMEWORKS FOR SUICIDE IDEATION AMONG PWH, AND OBTAIN COMPETENCY IN CLINICAL TRIAL DESIGN AND LONGITUDINAL DATA ANALYSIS. NOT ONLY WILL THESE TRAINING GOALS PROVIDE THE NECESSARY SKILLS TO DEVELOP, EVALUATE, AND IMPLEMENT SUICIDE INTERVENTIONS, BUT ALSO PROVIDE THE PLATFORM TO EMERGE AS A GLOBAL LEADER IN SUICIDE IN LMIC.

Posted 8/15/24